Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Young Girls' Experiences of Exposure to Pornography: A Qualitative Study

NCT07812662 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-04-15
Last updated
2026-09-10

Condition(s) studied

Exposure to Pornography

Investigational drug(s) / intervention(s)

Semi structured interview

Semi structured interview: Semi structured interview

Study summary

This qualitative study aims to explore the experiences, meanings, and uses of pornography among female adolescents and young women receiving care in child and adolescent psychiatry services. Participants aged 12 to 25 years will be recruited from inpatient and outpatient settings. Exclusion criteria will include an acute psychotic episode or an acute mood episode that could compromise participation in an interview.

Using semi-structured interviews, the study will examine the circumstances and age of first exposure to pornography; participants' emotional responses and evolving perceptions; subsequent patterns of viewing, use, avoidance, or sharing; and the roles pornography may play in their lives. Particular attention will be paid to its possible functions in relation to curiosity, sexual learning, arousal, identity exploration, peer relationships, emotional regulation, coercion, or distress.

The interviews will also explore how participants perceive the place of pornography in their relational and sexual trajectories, including its potential influence on expectations, consent, body image, sexual practices, intimate relationships, and current sexual life. Rather than assuming that pornography has uniformly harmful or beneficial effects, the study will seek to understand its diverse, ambivalent, and context-dependent meanings.

Finally, participants will be invited to formulate recommendations concerning public policy, pornography regulation, prevention, and sexuality education. By centring the perspectives of young female psychiatric service users, this study aims to contribute to a more nuanced understanding of pornography within contemporary adolescent development and clinical care.

Eligibility

Sex
FEMALE
Min age
11 Years
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria: * Girls aged 11 to 25 years who are being treated in the Child and Adolescent Psychiatry Department at CHITS or the follow-up clinic * Patient, or legal guardians if a minor, who does not object to the research; * Patient who engages in the consumption of pornographic content. Exclusion Criteria: * intellectual deficit * psychosis * acute mood episode * pregnant or breastfeeding * Patient under judicial protection

Primary outcome measure(s)

  • Qualitative content analysis of emotional experiences assessed via semi-structured interviews — At the single study visit (Day 1)
    Description of significant consequences experienced by female patients after viewing pornographic content: Cross coding of the verbatim

Trial sites (1)

FacilityCityRegionStatus
CHITS Toulon VAR Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07812662 on ClinicalTrials.gov ↗ ← All trials in France